Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2005
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP1465892A4 Glycinamides as factor xa inhibitors
11/30/2005EP1124827B1 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1702069A Alpha-piperazine substituted phenyl-propionic acid derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1702068A Alkanoyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229358C Novel tetrazolinone derivatives
11/30/2005CN1229352C Improved operational amplifier output unit
11/30/2005CN1229350C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/29/2005US6969710 Compounds
11/29/2005US6969709 Macrocycles useful in the treatment of Alzheimer's disease
11/29/2005CA2500217C Crystal forms of azithromycin
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2318160C Asymmetric cyanine dye quenchers
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111029A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005WO2005111025A1 3-piperidinylisochroman-5-ols as dopamine agonists
11/24/2005WO2005111023A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111018A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
11/24/2005WO2005111013A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
11/24/2005WO2005111005A1 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005110996A1 Novel cis-imidazolines
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110991A1 1-aryl-4-substituted isoquinolines
11/24/2005WO2005110983A1 Azetidine glycine transporter inhibitors
11/24/2005WO2005085198A3 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005WO2005046604A3 Heteroaryl-hydrazone compounds
11/24/2005WO2004091502A8 1,2,4-oxadiazole benzoic acid compounds
11/24/2005US20050261497 Catalytic asymmetric hetero diels-alder reaction of a heteroaromatic C-nitroso dienophile: a novel method for synthesis of chiral non-racemic amino alcohols
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261365 Transthyretin stabilization
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261332 Sulfonamides and uses thereof
11/24/2005US20050261325 Gamma-aminoamide modulators of chemokine receptor activity
11/24/2005US20050261322 HIV integrase inhibitors
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261311 Piperizinones as modulators of chemokine receptor activity
11/24/2005US20050261306 Anti-neurodegenerative agents
11/24/2005US20050261296 Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050261176 Compositions and methods relating to novel compounds and targets thereof
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2567154A1 Novel pyridazinone derivatives as inhibitors of cdk2
11/24/2005CA2566707A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2565407A1 Compounds for enzyme inhibition
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2565189A1 Cis-2,4,5-triphenyl imidazolines and their use as anti-cancer medicaments
11/24/2005CA2564517A1 1-aryl-4-substituted isoquinolines
11/24/2005CA2564501A1 Azetidine glycine transporter inhibitors
11/24/2005CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005CA2564207A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005CA2562714A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598345A1 Benzopyran compounds, process for preparing the same and their use
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597257A1 Oxazole-derivatives as ppar agonists
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005EP1597252A1 Pyridine derivatives as fungicidal compounds
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597247A1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597243A1 Heterocyclic compounds useful as nurr-1 activators
11/23/2005EP1597240A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
11/23/2005EP1597238A1 Hiv replication inhibiting pyrimidines and triazines
11/23/2005EP1597235A1 Non-nucleoside reverse transcriptase inhibitors
11/23/2005EP1597229A2 Pyrrolidine derivatives as oxytocin antagonists
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 647